128 related articles for article (PubMed ID: 1545781)
1. Development and characterization of a panel of monoclonal antibodies against the catalytic domain of the human fes proto-oncogene product.
van Bokhoven A; van Duijnhoven HL; Jücker M; Roebroek AJ; van de Ven WJ
Mol Biol Rep; 1992 Feb; 16(1):17-25. PubMed ID: 1545781
[TBL] [Abstract][Full Text] [Related]
2. Structure of the feline c-fes/fps proto-oncogene: genesis of a retroviral oncogene.
Roebroek AJ; Schalken JA; Onnekink C; Bloemers HP; Van de Ven WJ
J Virol; 1987 Jun; 61(6):2009-16. PubMed ID: 3553615
[TBL] [Abstract][Full Text] [Related]
3. Interaction of the c-fes proto-oncogene product with the interleukin-4 receptor.
Izuhara K; Feldman RA; Greer P; Harada N
J Biol Chem; 1994 Jul; 269(28):18623-9. PubMed ID: 7518439
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of the ras GTPase-activating protein (GAP) by the p93c-fes protein-tyrosine kinase in vitro and formation of GAP-fes complexes via an SH2 domain-dependent mechanism.
Hjermstad SJ; Briggs SD; Smithgall TE
Biochemistry; 1993 Oct; 32(39):10519-25. PubMed ID: 7691175
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of human trk proto-oncogene product monoclonal antibodies.
Eager KB
Oncogene; 1991 May; 6(5):819-24. PubMed ID: 2052359
[TBL] [Abstract][Full Text] [Related]
6. Application of recombinant DNA technology in epitope mapping and targeting. Development and characterization of a panel of monoclonal antibodies against the 7B2 neuroendocrine protein.
van Duijnhoven HL; Verschuren MC; Timmer ED; Vissers PM; Groeneveld A; Ayoubi TA; van den Ouweland AM; van de Ven WJ
J Immunol Methods; 1991 Sep; 142(2):187-98. PubMed ID: 1717598
[TBL] [Abstract][Full Text] [Related]
7. Malignant transformation of a human fibroblast cell strain by transfection of a v-fes oncogene but not by transfection of a gag-human c-fes construct.
Lin C; Wang Q; Maher VM; McCormick JJ
Cell Growth Differ; 1994 Dec; 5(12):1381-7. PubMed ID: 7696187
[TBL] [Abstract][Full Text] [Related]
8. Molecular cloning of the feline c-fes proto-oncogene and construction of a chimeric transforming gene.
Verbeek JS; van den Ouweland AM; Schalken JA; Roebroek AJ; Onnekink C; Bloemers HP; van de Ven WJ
Gene; 1985; 35(1-2):33-43. PubMed ID: 2993104
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the human c-fes protein tyrosine kinase (p93c-fes) by its src homology 2 domain and major autophosphorylation site (Tyr-713).
Hjermstad SJ; Peters KL; Briggs SD; Glazer RI; Smithgall TE
Oncogene; 1993 Aug; 8(8):2283-92. PubMed ID: 7687763
[TBL] [Abstract][Full Text] [Related]
10. Isolation and structural analysis of murine c-fes cDNA clones.
Wilks AF; Kurban RR
Oncogene; 1988 Sep; 3(3):289-94. PubMed ID: 3060793
[TBL] [Abstract][Full Text] [Related]
11. Characterization of human and mouse c-fes cDNA clones and identification of the 5' end of the gene.
Alcalay M; Antolini F; Van de Ven WJ; Lanfrancone L; Grignani F; Pelicci PG
Oncogene; 1990 Mar; 5(3):267-75. PubMed ID: 2179816
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic activation of the human trk proto-oncogene by recombination with the ribosomal large subunit protein L7a.
Ziemiecki A; Müller RG; Fu XC; Hynes NE; Kozma S
EMBO J; 1990 Jan; 9(1):191-6. PubMed ID: 2403926
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies specific to transforming polyproteins encoded by independent isolates of feline sarcoma virus.
Veronese F; Kelloff GJ; Reynolds FH; Hill RW; Stephenson JR
J Virol; 1982 Sep; 43(3):896-904. PubMed ID: 6183442
[TBL] [Abstract][Full Text] [Related]
14. Microsatellite instability in IVS3 of murine c-fes gene: tumor-associated rearrangement and mammalian divergence.
Volpi L; Beghini A; Rossi D; Larizza L
Mamm Genome; 1996 Sep; 7(9):682-5. PubMed ID: 8703122
[TBL] [Abstract][Full Text] [Related]
15. Src homology 2 domain substitution modulates the kinase and transforming activities of the Fes protein-tyrosine kinase.
Rogers JA; Cheng HY; Smithgall TE
Cell Growth Differ; 2000 Nov; 11(11):581-92. PubMed ID: 11095247
[TBL] [Abstract][Full Text] [Related]
16. Expression of the mammalian c-fes protein in hematopoietic cells and identification of a distinct fes-related protein.
MacDonald I; Levy J; Pawson T
Mol Cell Biol; 1985 Oct; 5(10):2543-51. PubMed ID: 2426571
[TBL] [Abstract][Full Text] [Related]
17. Myeloid expression of the human c-fps/fes proto-oncogene in transgenic mice.
Greer P; Maltby V; Rossant J; Bernstein A; Pawson T
Mol Cell Biol; 1990 Jun; 10(6):2521-7. PubMed ID: 2188092
[TBL] [Abstract][Full Text] [Related]
18. Molecular genetic characterization of epitope-specific monoclonal antibodies against the myc family proteins.
Ikegaki N; Kennett RH
Oncogene; 1990 Mar; 5(3):397-403. PubMed ID: 1690381
[TBL] [Abstract][Full Text] [Related]
19. Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1.
Bohmann D; Bos TJ; Admon A; Nishimura T; Vogt PK; Tjian R
Science; 1987 Dec; 238(4832):1386-92. PubMed ID: 2825349
[TBL] [Abstract][Full Text] [Related]
20. Expression of truncated transcripts of the proto-oncogene c-fps/fes in human lymphoma and lymphoid leukemia cell lines.
Jücker M; Roebroek AJ; Mautner J; Koch K; Eick D; Diehl V; Van de Ven WJ; Tesch H
Oncogene; 1992 May; 7(5):943-52. PubMed ID: 1373879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
